Choose Your Country or Region

Paricalcitol

Name: Paricalcitol
Brand: Selleck Chemicals
SKU: S6681
Rating: 5 (3 reviews)

Synonyms: Paracalcin,19-Nor-1-25-OH2D2,19-Nor-colecalciferol

Catalog No.S6681 Purity: 99.99%

Paricalcitol is a selective vitamin D receptor agonist. Paricalcitol suppresses parathyroid hormone mRNA expression and inhibits parathyroid cell proliferation. Pariccitol is used to treat secondary hyperparathyroidism in chronic kidney disease.

Paricalcitol Chemical Structure

CAS: 131918-61-1

Selleck's Paricalcitol has been cited by 3 publications

Purity & Quality Control

Batch: S668101 DMSO] 83 mg/mL] false] Ethanol] 13 mg/mL] false] Water] Insoluble] false Purity: 99.99%

99.99

Paricalcitol Related Products

Related Compound Libraries	Metabolism Compound Library Anti-cancer Metabolism Compound Library Glutamine Metabolism Compound Library Carbohydrate Metabolism Compound Library Lipid Metabolism Compound Library	Click to Expand

Choose Selective Vitamin Inhibitors

Biological Activity

Description

Targets

vitamin D receptor ^[1]

NCT Number	Recruitment	Conditions	Sponsor/Collaborators	Start Date	Phases
Clinical Trial Information (data from https://clinicaltrials.gov, updated on 2024-01-11)
NCT05664880	Recruiting	Chronic Pancreatitis	Cedars-Sinai Medical Center\|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	June 1 2023	Early Phase 1
NCT03415854	Completed	Pancreatic Cancer\|Pancreatic Ductal Adenocarcinoma\|Pancreatic Adenocarcinoma\|Pancreas Metastases\|Adenocarcinoma	HonorHealth Research Institute\|Barts Cancer Institute\|Abramson Cancer Center at Penn Medicine\|Salk Institute for Biological Studies\|Mayo Clinic\|Princeton University\|Imaging Endpoints\|Translational Genomics Research Institute\|Stand Up To Cancer\|Cancer Research UK\|Lustgarten Foundation\|University of California San Diego	January 31 2018	Phase 2
NCT03331562	Completed	Pancreatic Cancer\|Pancreas Adenocarcinoma\|Advanced Pancreatic Cancer\|Metastatic Pancreatic Cancer\|Metastatic Pancreatic Adenocarcinoma	Translational Genomics Research Institute\|Stand Up To Cancer\|Merck Sharp & Dohme LLC	December 27 2017	Phase 2
NCT02686827	Completed	Hypersensitivity	Laurian Jongejan\|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)	October 2015	Phase 2
NCT01725113	Terminated	Kidney Failure\|Secondary Hyperparathyroidism\|Hyperphosphatemia\|Hypercalcemia	Winthrop University Hospital	November 2012	Phase 4

References

Chemical Information & Solubility

Molecular Weight	416.64	Formula	C₂₇H₄₄O₃
CAS No.	131918-61-1	SDF	--
Smiles	CC(C=CC(C)C(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3)O)O)C
Storage (From the date of receipt)	3 years -20°C powder	Storage of Stock Solutions Aliquot the stock solutions to avoid repeated freeze-thaw cycles	1 year-80°Cin solvent
Storage (From the date of receipt)	3 years -20°C powder		1 month-20°Cin solvent

In vitro
Batch:

DMSO : 83 mg/mL ( (199.21 mM)； Moisture-absorbing DMSO reduces solubility. Please use fresh DMSO.)

Ethanol : 13 mg/mL

Water : Insoluble

Molecular Weight Calculator

In vivo
Batch:

Add solvents to the product individually and in order.

In vivo Formulation Calculator

Preparing Stock Solutions

Molarity Calculator

Dilution Calculator Molecular Weight Calculator

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

Dosage: mg/kg Average weight of animals: g Dosing volume per animal:μL Number of animals:

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO + % + % Tween 80 + % ddH₂O

%DMSO+ %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH₂O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

C1=C0/X	C1:	LOG(C1):
C2=C1/X	C2:	LOG(C2):
C3=C2/X	C3:	LOG(C3):
C4=C3/X	C4:	LOG(C4):
C5=C4/X	C5:	LOG(C5):
C6=C5/X	C6:	LOG(C6):
C7=C6/X	C7:	LOG(C7):
C8=C7/X	C8:	LOG(C8):